Author

Tiffany Lam

Weill Cornell MedicineORCID 0000-0002-9507-5819Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Tiffany Lam2 papers · The University of Texas at Dallas

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

André Lima QueiroziD· 1 shared Anirudh MurthyiD· 1 shared Baran A. ErsoyiD· 1 shared Eduardo Cararo LopesiD· 1 shared Eileen WhiteiD· 1 shared Ezequiel DantasiD· 1 shared Ido GoldsteiniD· 1 shared Isaac NathooiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

André Lima QueirozORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

JAK1/2 Inhibition Delays Cachexia and Improves Survival through Increased Food Intake

Ezequiel Dantas, Anirudh Murthy, Jeshua Kim, Tanvir Ahmed, Mujmmail Ahmed, Tiffany Perrier, Shakti Ramsamooj, Isaac Nathoo, Lucas Kniess Debarba, André Lima Queiroz, Shiri Li, Baran A. Ersoy, Miriam Ferrer, Ido Goldstein, Jonathan Gao, , Marcus DaSilva Goncalves

This study shows that JAK1/2 inhibition with ruxolitinib improves survival and body weight in lung cancer models by increasing food intake and restoring metabolic function.

bioRxiv · Oct 21, 2025 · PreprintCancer Biology